Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy.
暂无分享,去创建一个
Kenji Takazawa | Yasunori Ueda | Satoshi Saito | Osamu Yamaguchi | K. Takazawa | A. Hirayama | K. Kodama | S. Nanto | Yuxin Li | T. Takayama | J. Honye | S. Saito | S. Komatsu | O. Yamaguchi | Atsushi Hirayama | Shinsuke Nanto | Tadateru Takayama | J. Yajima | Sei Komatsu | Junko Honye | Y. Ueda | Kazuhisa Kodama | Junji Yajima | Yuxin Li
[1] Yasunori Ueda,et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: detection of vulnerable patients by angioscopy. , 2006, Journal of the American College of Cardiology.
[2] Raimund Erbel,et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.
[3] A. Hirayama,et al. Assessment of plaque vulnerability by angioscopic classification of plaque color. , 2004, American heart journal.
[4] M. Hori,et al. The healing process of infarct-related plaques. Insights from 18 months of serial angioscopic follow-up. , 2001, Journal of the American College of Cardiology.
[5] M Schartl,et al. Use of Intravascular Ultrasound to Compare Effects of Different Strategies of Lipid-Lowering Therapy on Plaque Volume and Composition in Patients With Coronary Artery Disease , 2001, Circulation.
[6] G Baumann,et al. Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. , 1996, Journal of the American College of Cardiology.
[7] Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.
[8] M. Ezekowitz,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.
[9] Chun Yuan,et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. , 2008, American heart journal.
[10] Bruce R. Brodie,et al. Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial , 2004 .
[11] K. Kanmatsuse,et al. Variability in quantitative measurement of the same segment with two different intravascular ultrasound systems: In vivo and in vitro studies , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[12] M. Takano,et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. , 2003, Journal of the American College of Cardiology.
[13] E. Braunwald,et al. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. , 2005, Journal of the American College of Cardiology.
[14] T. Akasaka,et al. Implication of plaque color classification for assessing plaque vulnerability: a coronary angioscopy and optical coherence tomography investigation. , 2008, JACC. Cardiovascular interventions.
[15] Ken Nagao,et al. Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. , 2005, The American journal of cardiology.
[16] K. Shimada,et al. Early Statin Treatment in Patients With Acute Coronary Syndrome: Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH Study , 2004, Circulation.
[17] V. Athyros,et al. Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention , 2002, Current medical research and opinion.
[18] J. LeLorier,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[19] P. Shah,et al. Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization , 2001, Circulation.
[20] H. Fujita,et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. , 2005, Journal of the American College of Cardiology.
[21] MasanoriKawasaki,et al. In Vivo Quantitative Tissue Characterization of Human Coronary Arterial Plaques by Use of Integrated Backscatter Intravascular Ultrasound and Comparison With Angioscopic Findings , 2002 .
[22] S. Nissen,et al. Coronary angiography and intravascular ultrasound. , 2001, The American journal of cardiology.
[23] P. Libby,et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. , 1998, Circulation.
[24] M. Hori,et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. , 2001, Journal of the American College of Cardiology.
[25] M. Clearfield. High-dose atorvastatin versus usual-dose simvastatin for secondary prevention after myocardial infarction. , 2007, Current atherosclerosis reports.
[26] S. Zarich,et al. Angioscopic assessment of coronary lesions underlying thrombus. , 1997, The American journal of cardiology.
[27] P. Fitzgerald,et al. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. , 2005, American heart journal.